Falling Price of Solar Affects India-U.S. Nuclear Deal
Amit Bhandari's article 'Quiet burial for the nuclear deal?' was republished by Worldpress.org
Amit Bhandari's article 'Quiet burial for the nuclear deal?' was republished by Worldpress.org
Amit Bhandari's article 'Quiet burial for the nuclear deal?' was republished by The Political Indian.
Amit Bhandari's article 'Quiet Burial for the India-U.S. nuclear deal?' was republished by Eurasia Review.
The island-nation of Maldives continues to go struggle. On 4 November, President Abdulla Yameen imposed Emergency in the country for a period of 30 days. Ambassador Neelam Deo, Director, Gateway House, talks about Operation Cactus and the current fall of disarray in Maldives.
The U.S. is urging India to alter its IPR regime, and the potential impact on prices in the pharmaceuticals sector is of concern to African countries that depend on India for low-cost generic medicines. The recent India-Africa Forum Summit in New Delhi sought to address this issue, but it will be a challenge for India to balance competing pressures.
Amit Bhandari's article 'Quiet burial for the nuclear deal?' was republished by Indian American Times.
Solar power developers have offered to sell electricity in India at less than Rs 5/unit. This makes solar competitive with traditional forms of energy, and makes new nuclear power plants financially unviable. India must register the changed reality, and discard the idea of expensive Western reactors. Time to scrap the India-U.S. nuclear deal?
Changes in how India plans to approach its relationship with Africa were evident at the recent India-Africa Forum Summit, including the wider representation of African countries, and Modi’s push to forge a united front with Africa at multilateral institutions on trade and other issues. But beyond these, gaps in the India-Africa alliance remain to be addressed.
Amit Bhandari's article 'How technology can cap oil prices' was republished by The Political Indian.
Patralekha Chatterjee's article 'Will the TPP impact Indian pharma?' was republished by DNA.